$INGR
Ingredion Inc

2022 Q2 Form 10-Q Financial Statement

#000155837022007571 Filed on May 06, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $2.044B $1.892B $1.755B
YoY Change 16.0% 17.22% 10.17%
Cost Of Revenue $1.654B $1.513B $1.465B
YoY Change 18.57% 19.79% 18.05%
Gross Profit $390.0M $379.0M $290.0M
YoY Change 6.27% 7.98% -17.61%
Gross Profit Margin 19.08% 20.03% 16.52%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $54.00M $53.00M $65.00M
YoY Change 5.88% 1.92% 18.18%
% of Gross Profit 13.85% 13.98% 22.41%
Operating Expenses $175.0M $167.0M $179.0M
YoY Change 24.11% 10.6% 30.66%
Operating Profit $215.0M $210.0M $111.0M
YoY Change -3.15% -223.53% -48.37%
Interest Expense -$17.00M -$24.00M -$16.00M
YoY Change -10.53% 26.32% -27.27%
% of Operating Profit -7.91% -11.43% -14.41%
Other Income/Expense, Net $0.00 $1.000M $8.000M
YoY Change -100.0% 0.0% 300.0%
Pretax Income $196.0M $187.0M $78.00M
YoY Change -4.39% -199.47% -45.45%
Income Tax $51.00M $54.00M $10.00M
% Of Pretax Income 26.02% 28.88% 12.82%
Net Earnings $142.0M $130.0M $67.00M
YoY Change -20.22% -152.85% -41.74%
Net Earnings / Revenue 6.95% 6.87% 3.82%
Basic Earnings Per Share $2.14 $1.94 $1.00
Diluted Earnings Per Share $2.116M $1.92 $0.99
COMMON SHARES
Basic Shares Outstanding 66.22M 66.90M 66.54M
Diluted Shares Outstanding 67.10M shares 67.60M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $322.0M $329.0M $340.0M
YoY Change -41.35% -42.98% -49.7%
Cash & Equivalents $318.0M $324.0M $328.0M
Short-Term Investments $4.000M $5.000M $12.00M
Other Short-Term Assets $56.00M $63.00M $63.00M
YoY Change -20.0% -8.7% 16.67%
Inventory $1.403B $1.306B $1.172B
Prepaid Expenses $63.00M $63.00M
Receivables $1.396B $1.431B $1.130B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.177B $3.129B $2.697B
YoY Change 12.94% 19.89% 1.89%
LONG-TERM ASSETS
Property, Plant & Equipment $2.375B $2.446B $2.423B
YoY Change -0.46% 3.86% -1.3%
Goodwill $914.0M
YoY Change 1.33%
Intangibles $434.0M
YoY Change -2.25%
Long-Term Investments $106.0M $104.0M
YoY Change 940.0%
Other Assets $524.0M $521.0M $531.0M
YoY Change 54.57% 76.01% 29.51%
Total Long-Term Assets $4.212B $4.306B $4.302B
YoY Change -1.7% 2.69% 2.16%
TOTAL ASSETS
Total Short-Term Assets $3.177B $3.129B $2.697B
Total Long-Term Assets $4.212B $4.306B $4.302B
Total Assets $7.389B $7.435B $6.999B
YoY Change 4.1% 9.29% 2.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.193B $1.207B $774.0M
YoY Change 21.24% 29.51% 29.22%
Accrued Expenses $430.0M
YoY Change 2.14%
Deferred Revenue
YoY Change
Short-Term Debt $652.0M $514.0M $308.0M
YoY Change 805.56% 655.88% 431.03%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.845B $1.721B $1.512B
YoY Change 67.57% 24.71% 3.7%
LONG-TERM LIABILITIES
Long-Term Debt $1.739B $1.739B $1.738B
YoY Change -18.32% -0.57% -0.57%
Other Long-Term Liabilities $574.0M $592.0M $82.00M
YoY Change 155.11% 170.32% -6.82%
Total Long-Term Liabilities $2.313B $1.739B $1.820B
YoY Change -1.74% -11.64% -0.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.845B $1.721B $1.512B
Total Long-Term Liabilities $2.313B $1.739B $1.820B
Total Liabilities $4.243B $4.021B $3.774B
YoY Change 2.09% -0.69% -0.32%
SHAREHOLDERS EQUITY
Retained Earnings $3.986B $3.899B
YoY Change 8.7% -1.47%
Common Stock $1.161B $1.159B
YoY Change 0.43% 0.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.146B $3.293B $3.100B
YoY Change
Total Liabilities & Shareholders Equity $7.389B $7.435B $6.999B
YoY Change 4.1% 9.29% 2.06%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income $142.0M $130.0M $67.00M
YoY Change -20.22% -152.85% -41.74%
Depreciation, Depletion And Amortization $54.00M $53.00M $65.00M
YoY Change 5.88% 1.92% 18.18%
Cash From Operating Activities $48.00M -$52.00M $133.0M
YoY Change -55.14% -336.36% -50.19%
INVESTING ACTIVITIES
Capital Expenditures -$59.00M $85.00M -$114.0M
YoY Change 51.28% 30.77% 26.67%
Acquisitions
YoY Change
Other Investing Activities -$1.000M -$4.000M $17.00M
YoY Change -98.15% -500.0% -180.95%
Cash From Investing Activities -$60.00M -$76.00M -$97.00M
YoY Change -35.48% 18.75% -12.61%
FINANCING ACTIVITIES
Cash Dividend Paid $43.00M
YoY Change 0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 26.00M 119.0M -137.0M
YoY Change -148.15% -397.5% 132.2%
NET CHANGE
Cash From Operating Activities 48.00M -52.00M 133.0M
Cash From Investing Activities -60.00M -76.00M -97.00M
Cash From Financing Activities 26.00M 119.0M -137.0M
Net Change In Cash 14.00M -4.000M -101.0M
YoY Change -135.0% -95.51% -204.12%
FREE CASH FLOW
Cash From Operating Activities $48.00M -$52.00M $133.0M
Capital Expenditures -$59.00M $85.00M -$114.0M
Free Cash Flow $107.0M -$137.0M $247.0M
YoY Change -26.71% 218.6% -30.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001046257
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
1-13397
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Ingredion Inc
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-3514823
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5 Westbrook Corporate Center
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Westchester
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60154
CY2022Q1 dei City Area Code
CityAreaCode
708
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
66219580
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1892000000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1614000000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000000
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
551-2600
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $.01 par value per share
CY2022Q1 dei Trading Symbol
TradingSymbol
INGR
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1513000000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1263000000
CY2022Q1 us-gaap Gross Profit
GrossProfit
379000000
CY2021Q1 us-gaap Gross Profit
GrossProfit
351000000
CY2022Q1 ingr Operating Expenses Excluding Restructuring Charges
OperatingExpensesExcludingRestructuringCharges
169000000
CY2021Q1 ingr Operating Expenses Excluding Restructuring Charges
OperatingExpensesExcludingRestructuringCharges
153000000
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2000000
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2000000
CY2022Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2000000
CY2021Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
370000000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
210000000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-170000000
CY2022Q1 ingr Financing Costs Net
FinancingCostsNet
24000000
CY2021Q1 ingr Financing Costs Net
FinancingCostsNet
19000000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
187000000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-188000000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
133000000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-243000000
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
130000000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-246000000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66900000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67300000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67600000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67300000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.66
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.92
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.66
CY2022Q1 us-gaap Profit Loss
ProfitLoss
133000000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-243000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
46000000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
7000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
130000000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
22000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
12000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
34000000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
1000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
38000000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-52000000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
267000000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-274000000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2000000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
5000000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
265000000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-279000000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
324000000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
328000000
CY2022Q1 us-gaap Other Short Term Investments
OtherShortTermInvestments
5000000
CY2021Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
4000000
CY2022Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
1431000000
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1130000000
CY2022Q1 us-gaap Inventory Net
InventoryNet
1306000000
CY2021Q4 us-gaap Inventory Net
InventoryNet
1172000000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
63000000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
63000000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
3129000000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
2697000000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3304000000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3232000000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2446000000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2423000000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
259000000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
253000000
CY2022Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1339000000
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1348000000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
521000000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
531000000
CY2022Q1 us-gaap Assets
Assets
7435000000
CY2021Q4 us-gaap Assets
Assets
6999000000
CY2022Q1 us-gaap Debt Current
DebtCurrent
514000000
CY2021Q4 us-gaap Debt Current
DebtCurrent
308000000
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1207000000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1204000000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1721000000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1512000000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1739000000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1738000000
CY2022Q1 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
561000000
CY2021Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
524000000
CY2022Q1 us-gaap Liabilities
Liabilities
4021000000
CY2021Q4 us-gaap Liabilities
Liabilities
3774000000
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
31000000
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
36000000
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
71000000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
71000000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77810875
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77810875
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1000000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1160000000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1158000000
CY2022Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11464034
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11154203
CY2022Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1091000000
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1061000000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-763000000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-897000000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3986000000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3899000000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3293000000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3100000000
CY2022Q1 us-gaap Nonredeemable Noncontrolling Interest
NonredeemableNoncontrollingInterest
19000000
CY2021Q4 us-gaap Nonredeemable Noncontrolling Interest
NonredeemableNoncontrollingInterest
18000000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3312000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3118000000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7435000000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6999000000
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
36000000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
71000000
CY2022Q1 ingr Temporary Equity Share Based Compensation Net Of Issuance
TemporaryEquityShareBasedCompensationNetOfIssuance
-5000000
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
31000000
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
71000000
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
30000000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
70000000
CY2021Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-1000000
CY2021Q1 ingr Temporary Equity Share Based Compensation Net Of Issuance
TemporaryEquityShareBasedCompensationNetOfIssuance
-9000000
CY2021Q1 ingr Temporary Equity Other Comprehensive Income
TemporaryEquityOtherComprehensiveIncome
1000000
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
21000000
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
70000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
133000000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-243000000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
53000000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
52000000
CY2022Q1 ingr Mechanical Stores Expense
MechanicalStoresExpense
13000000
CY2021Q1 ingr Mechanical Stores Expense
MechanicalStoresExpense
14000000
CY2021Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
360000000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3000000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4000000
CY2022Q1 ingr Other Non Cash Charges Credits To Net Income
OtherNonCashChargesCreditsToNetIncome
15000000
CY2021Q1 ingr Other Non Cash Charges Credits To Net Income
OtherNonCashChargesCreditsToNetIncome
7000000
CY2022Q1 ingr Increase Decrease In Accounts Receivable And Prepaid Expense
IncreaseDecreaseInAccountsReceivableAndPrepaidExpense
126000000
CY2021Q1 ingr Increase Decrease In Accounts Receivable And Prepaid Expense
IncreaseDecreaseInAccountsReceivableAndPrepaidExpense
56000000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
119000000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
69000000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-45000000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5000000
CY2022Q1 us-gaap Increase Decrease In Margin Deposits Outstanding
IncreaseDecreaseInMarginDepositsOutstanding
-28000000
CY2021Q1 us-gaap Increase Decrease In Margin Deposits Outstanding
IncreaseDecreaseInMarginDepositsOutstanding
16000000
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-7000000
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-18000000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52000000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22000000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
85000000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
65000000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000000
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4000000
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76000000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-64000000
CY2022Q1 ingr Proceeds From Borrowings
ProceedsFromBorrowings
147000000
CY2021Q1 ingr Proceeds From Borrowings
ProceedsFromBorrowings
46000000
CY2022Q1 ingr Payments On Debt
PaymentsOnDebt
123000000
CY2021Q1 ingr Payments On Debt
PaymentsOnDebt
36000000
CY2022Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
178000000
CY2022Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-39000000
CY2021Q1 us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-14000000
CY2022Q1 ingr Proceeds From Payments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans Net Of Settlements
ProceedsFromPaymentsOfIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansNetOfSettlements
-1000000
CY2021Q1 ingr Proceeds From Payments Of Issuance Of Shares Under Incentive And Share Based Compensation Plans Net Of Settlements
ProceedsFromPaymentsOfIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansNetOfSettlements
7000000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
43000000
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
43000000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
119000000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-40000000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5000000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7000000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4000000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-89000000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
328000000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
665000000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
324000000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
576000000
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
12000000
CY2022Q1 us-gaap Investments
Investments
130000000
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1000000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
88.66
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
36000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
57.65
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
13000
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
19000000
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
16000000
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
106000000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
104000000
CY2022Q1 us-gaap Marketable Securities
MarketableSecurities
5000000
CY2021Q4 us-gaap Investments
Investments
132000000
CY2021 ingr Equity Method Investment Transaction Cost
EquityMethodInvestmentTransactionCost
6000000
CY2022Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2000000
CY2021Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
370000000
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
360000000
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
10000000
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
2000000
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
10000000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
6000000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5000000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
281000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
358000
CY2021Q1 ingr Temporary Equity Other Comprehensive Income
TemporaryEquityOtherComprehensiveIncome
1000000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
117.27
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2386000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
90.54
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M8D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12000000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1805000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
91.34
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M21D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
12000000
CY2022Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
142000000
CY2022Q1 ingr Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months Tax
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsTax
50000000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
70000000
CY2021Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-1000000
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.64
CY2021Q1 ingr Temporary Equity Share Based Compensation Net Of Issuance
TemporaryEquityShareBasedCompensationNetOfIssuance
-9000000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1739000000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1738000000
CY2022Q1 us-gaap Debt Current
DebtCurrent
514000000
CY2021Q4 us-gaap Debt Current
DebtCurrent
308000000
CY2022Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2253000000
CY2021Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2046000000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1300000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2100000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-170000000
CY2022Q1 us-gaap Assets
Assets
7435000000
CY2021Q4 us-gaap Assets
Assets
6999000000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7000000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5000000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2154000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
90.39
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M3D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
26000000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
281000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.04
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.31
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5000000
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
36000000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
71000000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.65
CY2022Q1 ingr Temporary Equity Share Based Compensation Net Of Issuance
TemporaryEquityShareBasedCompensationNetOfIssuance
-5000000
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
31000000
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
71000000
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
30000000
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
21000000
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
70000000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
130000000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66900000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-246000000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67300000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.66
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
700000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
130000000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67600000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.92
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-246000000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67300000
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.66
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1892000000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1614000000
CY2022Q1 ingr Operating Income Loss Before Other Charges
OperatingIncomeLossBeforeOtherCharges
213000000
CY2021Q1 ingr Operating Income Loss Before Other Charges
OperatingIncomeLossBeforeOtherCharges
201000000
CY2022Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
1000000
CY2021Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
1000000
CY2022Q1 ingr Restructuring Settlement And Impairment Provisions Excluding Impairment Of Long Lived Assets To Be Disposed Of
RestructuringSettlementAndImpairmentProvisionsExcludingImpairmentOfLongLivedAssetsToBeDisposedOf
2000000
CY2021Q1 ingr Restructuring Settlement And Impairment Provisions Excluding Impairment Of Long Lived Assets To Be Disposed Of
RestructuringSettlementAndImpairmentProvisionsExcludingImpairmentOfLongLivedAssetsToBeDisposedOf
10000000
CY2021Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
360000000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
210000000
CY2022Q1 ingr Accounts Receivable Trade Current
AccountsReceivableTradeCurrent
1122000000
CY2021Q4 ingr Accounts Receivable Trade Current
AccountsReceivableTradeCurrent
950000000
CY2022Q1 ingr Accounts Receivable Other Current
AccountsReceivableOtherCurrent
324000000
CY2021Q4 ingr Accounts Receivable Other Current
AccountsReceivableOtherCurrent
193000000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
15000000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13000000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1431000000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1130000000
CY2022Q1 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
762000000
CY2021Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
688000000
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
428000000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
380000000
CY2022Q1 us-gaap Other Inventory Supplies
OtherInventorySupplies
116000000
CY2021Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
104000000
CY2022Q1 us-gaap Inventory Net
InventoryNet
1306000000
CY2021Q4 us-gaap Inventory Net
InventoryNet
1172000000

Files In Submission

Name View Source Status
0001558370-22-007571-index-headers.html Edgar Link pending
0001558370-22-007571-index.html Edgar Link pending
0001558370-22-007571.txt Edgar Link pending
0001558370-22-007571-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ingr-20220331.xsd Edgar Link pending
ingr-20220331x10q.htm Edgar Link pending
ingr-20220331x10q_htm.xml Edgar Link completed
ingr-20220331xex10d1.htm Edgar Link pending
ingr-20220331xex31d1.htm Edgar Link pending
ingr-20220331xex31d2.htm Edgar Link pending
ingr-20220331xex32d1.htm Edgar Link pending
ingr-20220331xex32d2.htm Edgar Link pending
ingr-20220331_cal.xml Edgar Link unprocessable
ingr-20220331_def.xml Edgar Link unprocessable
ingr-20220331_lab.xml Edgar Link unprocessable
ingr-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending